Published in Lung on August 29, 2017
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
A genome-wide perspective of genetic variation in human metabolism. Nat Genet (2009) 5.00
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol (2003) 2.19
Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung (2010) 1.65
The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol (2011) 1.58
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J (2010) 1.57
Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol (2006) 1.51
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease. Curr Cardiol Rev (2010) 1.50
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax (2008) 1.40
Asymmetric dimethylarginine is increased in asthma. Am J Respir Crit Care Med (2011) 1.25
[Metabolomics in diagnosing metabolic diseases]. Ther Umsch (2008) 1.19
Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.16
Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. BMC Health Serv Res (2007) 1.14
Lessons from ECLIPSE: a review of COPD biomarkers. Thorax (2013) 1.13
Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res (2009) 1.11
The COPD Biomarker Qualification Consortium (CBQC). COPD (2013) 1.06
Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arterioscler Thromb Vasc Biol (2013) 1.03
Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients. Br J Nutr (2011) 0.93
Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. Atherosclerosis (2014) 0.90
The emerging role of symmetric dimethylarginine in vascular disease. Adv Clin Chem (2009) 0.89
Arginase inhibition prevents inflammation and remodeling in a guinea pig model of chronic obstructive pulmonary disease. J Pharmacol Exp Ther (2014) 0.87
Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets (2006) 0.87
Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis. Mediators Inflamm (2013) 0.85
The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition. Nitric Oxide (2013) 0.85
Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections. Respir Res (2015) 0.85
Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type. COPD (2014) 0.84
Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study. J Intern Med (2015) 0.84
Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol (1999) 0.83
Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms. PLoS One (2016) 0.82
Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD). Int J Mol Sci (2014) 0.81
Asymmetric dimethylarginine predicts survival in the elderly. Age (Dordr) (2013) 0.81
A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities. J Pharmacol Exp Ther (2004) 0.81
Constitutive expressions of type I NOS in human airway smooth muscle cells: evidence for an antiproliferative role. FASEB J (1999) 0.81
ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis. Kidney Blood Press Res (2012) 0.79
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Clin Respir J (2015) 0.79
Acute and conditioned hypoxic tolerance augmented by endothelial nitric oxide synthase inhibition in mice. J Appl Physiol (1985) (2006) 0.78
Ratio Of Serum Asymmetric Dimethyl Arginine (ADMA)/ Nitric Oxide in Coronary Artery Disease patients. J Clin Diagn Res (2014) 0.78
L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker. COPD (2015) 0.78
Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile. Biomed Res Int (2014) 0.78
Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies. J Med Chem (2014) 0.77
Formulation, preclinical and clinical evaluation of a new submicronic arginine respiratory fluid for treatment of chronic obstructive pulmonary disorder. Saudi Pharm J (2015) 0.77
A critical examination of the ergogenic/therapeutic effects of supplementation to increase nitric oxide bioavailability. Nitric Oxide (2015) 0.76
Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease. Am J Clin Nutr (2016) 0.76